Newsletter Archives

Dear Friends, 

As we revel in the summer sun, we look optimistically at a future full of innovation and renewal. 

In this newsletter, we bring you good news for the Lakewood community and indeed the entire tri-state area. 

We are also including eye-opening updates from several conferences that created a stir in the OB/GYN arena. 

As always, we encourage you to reach out with any comments, questions, or requests. 

Wishing you a happy and healthy summer, 

Yitzchok Melber

WE ARE HONORED TO ANNOUNCE:

The opening of a new fertility clinic is always a reason for hope and excitement. But never have we been as delighted as we are now – with the launch of Conceive NJ, a state-of-the-art fertility center in the heart of Lakewood, NJ under the helm of our dear friend Dr. Isaac Glatstein. 

Dr. Glatstein has spent 22 years as the director of the IVF Center at Harvard University, overseeing the births of 70,000 babies, and has always been a visionary in the field. Now, he brings his expertise, sensitivity, and uniquely caring nature to the Orthodox community of Lakewood and beyond.

Rabbi and Mrs. Melber were privileged to meet with Dr. Glatstein and have only the most effusive praise. This is an incredible new revolution for the couples in our community facing infertility. 

Conceive NJ will offer the full workup and treatments to the community with cutting-edge treatments & procedures. 

Dr. Glatstein traveled the world in the last few years going to seminars and conferences bringing the latest innovations in treatments, processes and procedures, bringing these services in-house. 

Rabbi Melber’s warm and hearty relationship with Dr. Glatstein has been cemented throughout their mutual attendance at many medical conferences, and they continued to be in touch at every juncture throughout the planning and building stages of this unique facility. 

The care is personalized and culturally sensitive, which are both so essential to couples in this vulnerable state. 

We extend a warm and heartfelt Bracha to this incredible doctor and his dedicated team – may they see Hatzlacha in their hallowed endeavor and be Zoche to see many more Neshamos enter the world through their incredible care. 

Dr. Glatstein has a long-standing relationship with Tahareinu and the Lakewood community, speaking at the annual Tahareinu conference for Rabbonim and Kallah Teachers in Lakewood multiple times over the past few years.

Appointments can be made by calling the office at 732-806-1613, visiting their website conceivenj.com, or emailing info@conceivenj.com.

RABBI MELBER ATTENDS RCOG CONFERENCE

The Royal College of Gynecology conference in England takes place only once in 3 years – and is always a hotbed of innovation. 

Professor Joop Laven M.D PH.D. announced new guidelines for PCOS. Until now, in order to diagnose PCOS, a patient had to have 2 out of the 3 main symptoms: Acne, irregular cycles, and an ultrasound showing (many) undeveloped follicles.  

The updated recommendation (in addition to the above symptoms) for diagnosing PCOS has changed to include a simple AMH blood test. The benefits include easier access and greater clarity, as well as determining POI issues simultaneously. 

In the States and the UK this test is covered; in Israel it is still private. 

Dr. Scott Nelson delivered a lecture on role of AMH in fertility preservations and beyond. Whenever the question of whether to freeze eggs or not arises, either because someone is approaching age 30, has endometriosis, or, is undergoing chemo – how do we determine the protocol? 

Usually AMH can give us the info regarding the ovarian reserve in order to provide the answer. 

Oncology patients should undergo egg-freezing before starting chemotherapy treatments, and perform the test before and after chemotherapy. Girls who have not begun menstruating by their late teens, or, who have not had a period for a full year should take this test and repeat it every year that their AMH is showing low.

AMH has a wealth of additional uses that are now beginning to be fully realized. 

At Tahareinu, we recommend this test often when we see the need.

Dr. Ippokratis Sarris, Director and Consultant in Reproductive Medicine at King’s Fertility delivered another lecture focusing on two reasons for failed IVF: Thrombophilia (clotting) and immunology. He recommended that after RIF or 3 or more failed IVF cycles these 2 factors should be investigated. 

Professor Adam Balen, Professor of Reproductive Medicine at Leeds Hospital in the UK and member of FIGO, released a new classification of disorders of ovulation (#1 cause of female infertility) – known as the HyPOP classification: Hypothalamic Pituitary Ovarian PCOS. 

This tool is another major advancement that puts the whole field of infertility into a new phase of progress allowing for greater investigation and treatment.

Another lecture, “The Forgotten Father – Male Factors in Miscarriage” was delivered by Dr. Stephen Gordon of the Center of Reproductive Immunology and Pregnancy. Dr. Gordon brought the guidelines from the American Urology Association, or AUA, in 2021: In couples with failed ART cycles or RPL, the male partner should be evaluated with a focus on sperm DNA. The European Association of Urology, or EAU, in 2020 states that couples with RPL and men with unexplained male infertility indicate that sperm DNA may be damaged. The new 6th Edition WHO recommends testing DFI (DNA Fragmentation Indix) as a cause for infertility and/or miscarriages. 

Dr. Sarah Robertson delivered a lecture on the topic of immunotherapy. Dr. Robertson posited that a healthy immune response helps pregnancy success, and focused on the importance of immune response in helping healthy implantation and placental development. In Dr. Robertson’s opinion, poor immune response raises the risk of pregnancy loss, specifically with first pregnancy or RIF.

In order to improve immune response, one should first incorporate lifestyle changes: increase vegetable and protein in one’s diet, and exercise, considering that people with obesity have weaker immune profiles. 

The next step would be medications: Intra-lipid, IVIG, and others, which in some cases would be beneficial and recommended for immune disorders.

UTERINE TRANSPLANTS: THE WAVE OF THE FUTURE

At a recent Israeli conference, Rabbi Melber was fortunate to meet Dr.  Ben-Shachar, who is developing a method for uterine transplants which has already been approved by the Israeli government. This procedure will be free for Israelis – with the same high level treatment as in the US, where it costs roughly $300,000!

In general, it is often worthwhile for couples to come to Israel for fertility treatments, which are considerably more affordable even when paying privately.

TAHAREINU LIVE SHIURIM – COMING TO YOUR COMMUNITY!

Tahareinu had the honor hosting 6 shiurim around Yerushalaim during the past 4 weeks. Four shiurim were given to Rabbonim in Ramat Eshkol, Romemma, Bircas Moshe and Ganei Geulah, and two shiurim for women in the Sanhedria/Ramat Eshkol neighborhoods. Tahareinu will I”H be hosting shiurim in Melbourne, AU during the month of Tammuz, along with multiple shiurim in the Arze Habira neighborhood of Yerushalaim. 

If you would like Tahareinu to come to your community please reach out to tzvi.goldman@tahareinu.com.

In the past 8 weeks we’ve hosted shiurim in:

TAHAREINU PROFESSIONAL COURSE – LAST CHANCE!

Our English course is sold out and underway, with close to 100 Rabbanim, Kallah teachers, and professionals from around the world enrolled. (The course is recorded, for information pertaining to the course/recordings please email tzvi.goldman@tahareinu.com

The Yiddish course is starting this Monday, July 4! To enroll, please email tzvi.goldman@tahareinu.com

Dear Friends, 

As we revel in the summer sun, we look optimistically at a future full of innovation and renewal. 

In this newsletter, we bring you good news for the Lakewood community and indeed the entire tri-state area. 

We are also including eye-opening updates from several conferences that created a stir in the OB/GYN arena. 

As always, we encourage you to reach out with any comments, questions, or requests. 

Wishing you a happy and healthy summer, 

Yitzchok Melber

WE ARE HONORED TO ANNOUNCE:

The opening of a new fertility clinic is always a reason for hope and excitement. But never have we been as delighted as we are now – with the launch of Conceive NJ, a state-of-the-art fertility center in the heart of Lakewood, NJ under the helm of our dear friend Dr. Isaac Glatstein. 

Dr. Glatstein has spent 22 years as the director of the IVF Center at Harvard University, overseeing the births of 70,000 babies, and has always been a visionary in the field. Now, he brings his expertise, sensitivity, and uniquely caring nature to the Orthodox community of Lakewood and beyond.

Rabbi and Mrs. Melber were privileged to meet with Dr. Glatstein and have only the most effusive praise. This is an incredible new revolution for the couples in our community facing infertility. 

Conceive NJ will offer the full workup and treatments to the community with cutting-edge treatments & procedures. 

Dr. Glatstein traveled the world in the last few years going to seminars and conferences bringing the latest innovations in treatments, processes and procedures, bringing these services in-house. 

Rabbi Melber’s warm and hearty relationship with Dr. Glatstein has been cemented throughout their mutual attendance at many medical conferences, and they continued to be in touch at every juncture throughout the planning and building stages of this unique facility. 

The care is personalized and culturally sensitive, which are both so essential to couples in this vulnerable state. 

We extend a warm and heartfelt Bracha to this incredible doctor and his dedicated team – may they see Hatzlacha in their hallowed endeavor and be Zoche to see many more Neshamos enter the world through their incredible care. 

Dr. Glatstein has a long-standing relationship with Tahareinu and the Lakewood community, speaking at the annual Tahareinu conference for Rabbonim and Kallah Teachers in Lakewood multiple times over the past few years.

Appointments can be made by calling the office at 732-806-1613, visiting their website conceivenj.com, or emailing info@conceivenj.com.

RABBI MELBER ATTENDS RCOG CONFERENCE

The Royal College of Gynecology conference in England takes place only once in 3 years – and is always a hotbed of innovation. 

Professor Joop Laven M.D PH.D. announced new guidelines for PCOS. Until now, in order to diagnose PCOS, a patient had to have 2 out of the 3 main symptoms: Acne, irregular cycles, and an ultrasound showing (many) undeveloped follicles.  

The updated recommendation (in addition to the above symptoms) for diagnosing PCOS has changed to include a simple AMH blood test. The benefits include easier access and greater clarity, as well as determining POI issues simultaneously. 

In the States and the UK this test is covered; in Israel it is still private. 

Dr. Scott Nelson delivered a lecture on role of AMH in fertility preservations and beyond. Whenever the question of whether to freeze eggs or not arises, either because someone is approaching age 30, has endometriosis, or, is undergoing chemo – how do we determine the protocol? 

Usually AMH can give us the info regarding the ovarian reserve in order to provide the answer. 

Oncology patients should undergo egg-freezing before starting chemotherapy treatments, and perform the test before and after chemotherapy. Girls who have not begun menstruating by their late teens, or, who have not had a period for a full year should take this test and repeat it every year that their AMH is showing low.

AMH has a wealth of additional uses that are now beginning to be fully realized. 

At Tahareinu, we recommend this test often when we see the need.

Dr. Ippokratis Sarris, Director and Consultant in Reproductive Medicine at King’s Fertility delivered another lecture focusing on two reasons for failed IVF: Thrombophilia (clotting) and immunology. He recommended that after RIF or 3 or more failed IVF cycles these 2 factors should be investigated. 

Professor Adam Balen, Professor of Reproductive Medicine at Leeds Hospital in the UK and member of FIGO, released a new classification of disorders of ovulation (#1 cause of female infertility) – known as the HyPOP classification: Hypothalamic Pituitary Ovarian PCOS. 

This tool is another major advancement that puts the whole field of infertility into a new phase of progress allowing for greater investigation and treatment.

Another lecture, “The Forgotten Father – Male Factors in Miscarriage” was delivered by Dr. Stephen Gordon of the Center of Reproductive Immunology and Pregnancy. Dr. Gordon brought the guidelines from the American Urology Association, or AUA, in 2021: In couples with failed ART cycles or RPL, the male partner should be evaluated with a focus on sperm DNA. The European Association of Urology, or EAU, in 2020 states that couples with RPL and men with unexplained male infertility indicate that sperm DNA may be damaged. The new 6th Edition WHO recommends testing DFI (DNA Fragmentation Indix) as a cause for infertility and/or miscarriages. 

Dr. Sarah Robertson delivered a lecture on the topic of immunotherapy. Dr. Robertson posited that a healthy immune response helps pregnancy success, and focused on the importance of immune response in helping healthy implantation and placental development. In Dr. Robertson’s opinion, poor immune response raises the risk of pregnancy loss, specifically with first pregnancy or RIF.

In order to improve immune response, one should first incorporate lifestyle changes: increase vegetable and protein in one’s diet, and exercise, considering that people with obesity have weaker immune profiles. 

The next step would be medications: Intra-lipid, IVIG, and others, which in some cases would be beneficial and recommended for immune disorders.

UTERINE TRANSPLANTS: THE WAVE OF THE FUTURE

At a recent Israeli conference, Rabbi Melber was fortunate to meet Dr.  Ben-Shachar, who is developing a method for uterine transplants which has already been approved by the Israeli government. This procedure will be free for Israelis – with the same high level treatment as in the US, where it costs roughly $300,000!

In general, it is often worthwhile for couples to come to Israel for fertility treatments, which are considerably more affordable even when paying privately.

TAHAREINU LIVE SHIURIM – COMING TO YOUR COMMUNITY!

Tahareinu had the honor hosting 6 shiurim around Yerushalaim during the past 4 weeks. Four shiurim were given to Rabbonim in Ramat Eshkol, Romemma, Bircas Moshe and Ganei Geulah, and two shiurim for women in the Sanhedria/Ramat Eshkol neighborhoods. Tahareinu will I”H be hosting shiurim in Melbourne, AU during the month of Tammuz, along with multiple shiurim in the Arze Habira neighborhood of Yerushalaim. 

If you would like Tahareinu to come to your community please reach out to tzvi.goldman@tahareinu.com.

In the past 8 weeks we’ve hosted shiurim in:

TAHAREINU PROFESSIONAL COURSE – LAST CHANCE!

Our English course is sold out and underway, with close to 100 Rabbanim, Kallah teachers, and professionals from around the world enrolled. (The course is recorded, for information pertaining to the course/recordings please email tzvi.goldman@tahareinu.com

The Yiddish course is starting this Monday, July 4! To enroll, please email tzvi.goldman@tahareinu.com

Dear Friends, 

As we revel in the summer sun, we look optimistically at a future full of innovation and renewal. 

In this newsletter, we bring you good news for the Lakewood community and indeed the entire tri-state area. 

We are also including eye-opening updates from several conferences that created a stir in the OB/GYN arena. 

As always, we encourage you to reach out with any comments, questions, or requests. 

Wishing you a happy and healthy summer, 

Yitzchok Melber

WE ARE HONORED TO ANNOUNCE:

The opening of a new fertility clinic is always a reason for hope and excitement. But never have we been as delighted as we are now – with the launch of Conceive NJ, a state-of-the-art fertility center in the heart of Lakewood, NJ under the helm of our dear friend Dr. Isaac Glatstein. 

Dr. Glatstein has spent 22 years as the director of the IVF Center at Harvard University, overseeing the births of 70,000 babies, and has always been a visionary in the field. Now, he brings his expertise, sensitivity, and uniquely caring nature to the Orthodox community of Lakewood and beyond.

Rabbi and Mrs. Melber were privileged to meet with Dr. Glatstein and have only the most effusive praise. This is an incredible new revolution for the couples in our community facing infertility. 

Conceive NJ will offer the full workup and treatments to the community with cutting-edge treatments & procedures. 

Dr. Glatstein traveled the world in the last few years going to seminars and conferences bringing the latest innovations in treatments, processes and procedures, bringing these services in-house. 

Rabbi Melber’s warm and hearty relationship with Dr. Glatstein has been cemented throughout their mutual attendance at many medical conferences, and they continued to be in touch at every juncture throughout the planning and building stages of this unique facility. 

The care is personalized and culturally sensitive, which are both so essential to couples in this vulnerable state. 

We extend a warm and heartfelt Bracha to this incredible doctor and his dedicated team – may they see Hatzlacha in their hallowed endeavor and be Zoche to see many more Neshamos enter the world through their incredible care. 

Dr. Glatstein has a long-standing relationship with Tahareinu and the Lakewood community, speaking at the annual Tahareinu conference for Rabbonim and Kallah Teachers in Lakewood multiple times over the past few years.

Appointments can be made by calling the office at 732-806-1613, visiting their website conceivenj.com, or emailing info@conceivenj.com.

RABBI MELBER ATTENDS RCOG CONFERENCE

The Royal College of Gynecology conference in England takes place only once in 3 years – and is always a hotbed of innovation. 

Professor Joop Laven M.D PH.D. announced new guidelines for PCOS. Until now, in order to diagnose PCOS, a patient had to have 2 out of the 3 main symptoms: Acne, irregular cycles, and an ultrasound showing (many) undeveloped follicles.  

The updated recommendation (in addition to the above symptoms) for diagnosing PCOS has changed to include a simple AMH blood test. The benefits include easier access and greater clarity, as well as determining POI issues simultaneously. 

In the States and the UK this test is covered; in Israel it is still private. 

Dr. Scott Nelson delivered a lecture on role of AMH in fertility preservations and beyond. Whenever the question of whether to freeze eggs or not arises, either because someone is approaching age 30, has endometriosis, or, is undergoing chemo – how do we determine the protocol? 

Usually AMH can give us the info regarding the ovarian reserve in order to provide the answer. 

Oncology patients should undergo egg-freezing before starting chemotherapy treatments, and perform the test before and after chemotherapy. Girls who have not begun menstruating by their late teens, or, who have not had a period for a full year should take this test and repeat it every year that their AMH is showing low.

AMH has a wealth of additional uses that are now beginning to be fully realized. 

At Tahareinu, we recommend this test often when we see the need.

Dr. Ippokratis Sarris, Director and Consultant in Reproductive Medicine at King’s Fertility delivered another lecture focusing on two reasons for failed IVF: Thrombophilia (clotting) and immunology. He recommended that after RIF or 3 or more failed IVF cycles these 2 factors should be investigated. 

Professor Adam Balen, Professor of Reproductive Medicine at Leeds Hospital in the UK and member of FIGO, released a new classification of disorders of ovulation (#1 cause of female infertility) – known as the HyPOP classification: Hypothalamic Pituitary Ovarian PCOS. 

This tool is another major advancement that puts the whole field of infertility into a new phase of progress allowing for greater investigation and treatment.

Another lecture, “The Forgotten Father – Male Factors in Miscarriage” was delivered by Dr. Stephen Gordon of the Center of Reproductive Immunology and Pregnancy. Dr. Gordon brought the guidelines from the American Urology Association, or AUA, in 2021: In couples with failed ART cycles or RPL, the male partner should be evaluated with a focus on sperm DNA. The European Association of Urology, or EAU, in 2020 states that couples with RPL and men with unexplained male infertility indicate that sperm DNA may be damaged. The new 6th Edition WHO recommends testing DFI (DNA Fragmentation Indix) as a cause for infertility and/or miscarriages. 

Dr. Sarah Robertson delivered a lecture on the topic of immunotherapy. Dr. Robertson posited that a healthy immune response helps pregnancy success, and focused on the importance of immune response in helping healthy implantation and placental development. In Dr. Robertson’s opinion, poor immune response raises the risk of pregnancy loss, specifically with first pregnancy or RIF.

In order to improve immune response, one should first incorporate lifestyle changes: increase vegetable and protein in one’s diet, and exercise, considering that people with obesity have weaker immune profiles. 

The next step would be medications: Intra-lipid, IVIG, and others, which in some cases would be beneficial and recommended for immune disorders.

UTERINE TRANSPLANTS: THE WAVE OF THE FUTURE

At a recent Israeli conference, Rabbi Melber was fortunate to meet Dr.  Ben-Shachar, who is developing a method for uterine transplants which has already been approved by the Israeli government. This procedure will be free for Israelis – with the same high level treatment as in the US, where it costs roughly $300,000!

In general, it is often worthwhile for couples to come to Israel for fertility treatments, which are considerably more affordable even when paying privately.

TAHAREINU LIVE SHIURIM – COMING TO YOUR COMMUNITY!

Tahareinu had the honor hosting 6 shiurim around Yerushalaim during the past 4 weeks. Four shiurim were given to Rabbonim in Ramat Eshkol, Romemma, Bircas Moshe and Ganei Geulah, and two shiurim for women in the Sanhedria/Ramat Eshkol neighborhoods. Tahareinu will I”H be hosting shiurim in Melbourne, AU during the month of Tammuz, along with multiple shiurim in the Arze Habira neighborhood of Yerushalaim. 

If you would like Tahareinu to come to your community please reach out to tzvi.goldman@tahareinu.com.

In the past 8 weeks we’ve hosted shiurim in:

TAHAREINU PROFESSIONAL COURSE – LAST CHANCE!

Our English course is sold out and underway, with close to 100 Rabbanim, Kallah teachers, and professionals from around the world enrolled. (The course is recorded, for information pertaining to the course/recordings please email tzvi.goldman@tahareinu.com

The Yiddish course is starting this Monday, July 4! To enroll, please email tzvi.goldman@tahareinu.com

Dear Friends, 

As we revel in the summer sun, we look optimistically at a future full of innovation and renewal. 

In this newsletter, we bring you good news for the Lakewood community and indeed the entire tri-state area. 

We are also including eye-opening updates from several conferences that created a stir in the OB/GYN arena. 

As always, we encourage you to reach out with any comments, questions, or requests. 

Wishing you a happy and healthy summer, 

Yitzchok Melber

WE ARE HONORED TO ANNOUNCE:

The opening of a new fertility clinic is always a reason for hope and excitement. But never have we been as delighted as we are now – with the launch of Conceive NJ, a state-of-the-art fertility center in the heart of Lakewood, NJ under the helm of our dear friend Dr. Isaac Glatstein. 

Dr. Glatstein has spent 22 years as the director of the IVF Center at Harvard University, overseeing the births of 70,000 babies, and has always been a visionary in the field. Now, he brings his expertise, sensitivity, and uniquely caring nature to the Orthodox community of Lakewood and beyond.

Rabbi and Mrs. Melber were privileged to meet with Dr. Glatstein and have only the most effusive praise. This is an incredible new revolution for the couples in our community facing infertility. 

Conceive NJ will offer the full workup and treatments to the community with cutting-edge treatments & procedures. 

Dr. Glatstein traveled the world in the last few years going to seminars and conferences bringing the latest innovations in treatments, processes and procedures, bringing these services in-house. 

Rabbi Melber’s warm and hearty relationship with Dr. Glatstein has been cemented throughout their mutual attendance at many medical conferences, and they continued to be in touch at every juncture throughout the planning and building stages of this unique facility. 

The care is personalized and culturally sensitive, which are both so essential to couples in this vulnerable state. 

We extend a warm and heartfelt Bracha to this incredible doctor and his dedicated team – may they see Hatzlacha in their hallowed endeavor and be Zoche to see many more Neshamos enter the world through their incredible care. 

Dr. Glatstein has a long-standing relationship with Tahareinu and the Lakewood community, speaking at the annual Tahareinu conference for Rabbonim and Kallah Teachers in Lakewood multiple times over the past few years.

Appointments can be made by calling the office at 732-806-1613, visiting their website conceivenj.com, or emailing info@conceivenj.com.

RABBI MELBER ATTENDS RCOG CONFERENCE

The Royal College of Gynecology conference in England takes place only once in 3 years – and is always a hotbed of innovation. 

Professor Joop Laven M.D PH.D. announced new guidelines for PCOS. Until now, in order to diagnose PCOS, a patient had to have 2 out of the 3 main symptoms: Acne, irregular cycles, and an ultrasound showing (many) undeveloped follicles.  

The updated recommendation (in addition to the above symptoms) for diagnosing PCOS has changed to include a simple AMH blood test. The benefits include easier access and greater clarity, as well as determining POI issues simultaneously. 

In the States and the UK this test is covered; in Israel it is still private. 

Dr. Scott Nelson delivered a lecture on role of AMH in fertility preservations and beyond. Whenever the question of whether to freeze eggs or not arises, either because someone is approaching age 30, has endometriosis, or, is undergoing chemo – how do we determine the protocol? 

Usually AMH can give us the info regarding the ovarian reserve in order to provide the answer. 

Oncology patients should undergo egg-freezing before starting chemotherapy treatments, and perform the test before and after chemotherapy. Girls who have not begun menstruating by their late teens, or, who have not had a period for a full year should take this test and repeat it every year that their AMH is showing low.

AMH has a wealth of additional uses that are now beginning to be fully realized. 

At Tahareinu, we recommend this test often when we see the need.

Dr. Ippokratis Sarris, Director and Consultant in Reproductive Medicine at King’s Fertility delivered another lecture focusing on two reasons for failed IVF: Thrombophilia (clotting) and immunology. He recommended that after RIF or 3 or more failed IVF cycles these 2 factors should be investigated. 

Professor Adam Balen, Professor of Reproductive Medicine at Leeds Hospital in the UK and member of FIGO, released a new classification of disorders of ovulation (#1 cause of female infertility) – known as the HyPOP classification: Hypothalamic Pituitary Ovarian PCOS. 

This tool is another major advancement that puts the whole field of infertility into a new phase of progress allowing for greater investigation and treatment.

Another lecture, “The Forgotten Father – Male Factors in Miscarriage” was delivered by Dr. Stephen Gordon of the Center of Reproductive Immunology and Pregnancy. Dr. Gordon brought the guidelines from the American Urology Association, or AUA, in 2021: In couples with failed ART cycles or RPL, the male partner should be evaluated with a focus on sperm DNA. The European Association of Urology, or EAU, in 2020 states that couples with RPL and men with unexplained male infertility indicate that sperm DNA may be damaged. The new 6th Edition WHO recommends testing DFI (DNA Fragmentation Indix) as a cause for infertility and/or miscarriages. 

Dr. Sarah Robertson delivered a lecture on the topic of immunotherapy. Dr. Robertson posited that a healthy immune response helps pregnancy success, and focused on the importance of immune response in helping healthy implantation and placental development. In Dr. Robertson’s opinion, poor immune response raises the risk of pregnancy loss, specifically with first pregnancy or RIF.

In order to improve immune response, one should first incorporate lifestyle changes: increase vegetable and protein in one’s diet, and exercise, considering that people with obesity have weaker immune profiles. 

The next step would be medications: Intra-lipid, IVIG, and others, which in some cases would be beneficial and recommended for immune disorders.

UTERINE TRANSPLANTS: THE WAVE OF THE FUTURE

At a recent Israeli conference, Rabbi Melber was fortunate to meet Dr.  Ben-Shachar, who is developing a method for uterine transplants which has already been approved by the Israeli government. This procedure will be free for Israelis – with the same high level treatment as in the US, where it costs roughly $300,000!

In general, it is often worthwhile for couples to come to Israel for fertility treatments, which are considerably more affordable even when paying privately.

TAHAREINU LIVE SHIURIM – COMING TO YOUR COMMUNITY!

Tahareinu had the honor hosting 6 shiurim around Yerushalaim during the past 4 weeks. Four shiurim were given to Rabbonim in Ramat Eshkol, Romemma, Bircas Moshe and Ganei Geulah, and two shiurim for women in the Sanhedria/Ramat Eshkol neighborhoods. Tahareinu will I”H be hosting shiurim in Melbourne, AU during the month of Tammuz, along with multiple shiurim in the Arze Habira neighborhood of Yerushalaim. 

If you would like Tahareinu to come to your community please reach out to tzvi.goldman@tahareinu.com.

In the past 8 weeks we’ve hosted shiurim in:

TAHAREINU PROFESSIONAL COURSE – LAST CHANCE!

Our English course is sold out and underway, with close to 100 Rabbanim, Kallah teachers, and professionals from around the world enrolled. (The course is recorded, for information pertaining to the course/recordings please email tzvi.goldman@tahareinu.com

The Yiddish course is starting this Monday, July 4! To enroll, please email tzvi.goldman@tahareinu.com

Dear Friends, 

As we revel in the summer sun, we look optimistically at a future full of innovation and renewal. 

In this newsletter, we bring you good news for the Lakewood community and indeed the entire tri-state area. 

We are also including eye-opening updates from several conferences that created a stir in the OB/GYN arena. 

As always, we encourage you to reach out with any comments, questions, or requests. 

Wishing you a happy and healthy summer, 

Yitzchok Melber

WE ARE HONORED TO ANNOUNCE:

The opening of a new fertility clinic is always a reason for hope and excitement. But never have we been as delighted as we are now – with the launch of Conceive NJ, a state-of-the-art fertility center in the heart of Lakewood, NJ under the helm of our dear friend Dr. Isaac Glatstein. 

Dr. Glatstein has spent 22 years as the director of the IVF Center at Harvard University, overseeing the births of 70,000 babies, and has always been a visionary in the field. Now, he brings his expertise, sensitivity, and uniquely caring nature to the Orthodox community of Lakewood and beyond.

Rabbi and Mrs. Melber were privileged to meet with Dr. Glatstein and have only the most effusive praise. This is an incredible new revolution for the couples in our community facing infertility. 

Conceive NJ will offer the full workup and treatments to the community with cutting-edge treatments & procedures. 

Dr. Glatstein traveled the world in the last few years going to seminars and conferences bringing the latest innovations in treatments, processes and procedures, bringing these services in-house. 

Rabbi Melber’s warm and hearty relationship with Dr. Glatstein has been cemented throughout their mutual attendance at many medical conferences, and they continued to be in touch at every juncture throughout the planning and building stages of this unique facility. 

The care is personalized and culturally sensitive, which are both so essential to couples in this vulnerable state. 

We extend a warm and heartfelt Bracha to this incredible doctor and his dedicated team – may they see Hatzlacha in their hallowed endeavor and be Zoche to see many more Neshamos enter the world through their incredible care. 

Dr. Glatstein has a long-standing relationship with Tahareinu and the Lakewood community, speaking at the annual Tahareinu conference for Rabbonim and Kallah Teachers in Lakewood multiple times over the past few years.

Appointments can be made by calling the office at 732-806-1613, visiting their website conceivenj.com, or emailing info@conceivenj.com.

RABBI MELBER ATTENDS RCOG CONFERENCE

The Royal College of Gynecology conference in England takes place only once in 3 years – and is always a hotbed of innovation. 

Professor Joop Laven M.D PH.D. announced new guidelines for PCOS. Until now, in order to diagnose PCOS, a patient had to have 2 out of the 3 main symptoms: Acne, irregular cycles, and an ultrasound showing (many) undeveloped follicles.  

The updated recommendation (in addition to the above symptoms) for diagnosing PCOS has changed to include a simple AMH blood test. The benefits include easier access and greater clarity, as well as determining POI issues simultaneously. 

In the States and the UK this test is covered; in Israel it is still private. 

Dr. Scott Nelson delivered a lecture on role of AMH in fertility preservations and beyond. Whenever the question of whether to freeze eggs or not arises, either because someone is approaching age 30, has endometriosis, or, is undergoing chemo – how do we determine the protocol? 

Usually AMH can give us the info regarding the ovarian reserve in order to provide the answer. 

Oncology patients should undergo egg-freezing before starting chemotherapy treatments, and perform the test before and after chemotherapy. Girls who have not begun menstruating by their late teens, or, who have not had a period for a full year should take this test and repeat it every year that their AMH is showing low.

AMH has a wealth of additional uses that are now beginning to be fully realized. 

At Tahareinu, we recommend this test often when we see the need.

Dr. Ippokratis Sarris, Director and Consultant in Reproductive Medicine at King’s Fertility delivered another lecture focusing on two reasons for failed IVF: Thrombophilia (clotting) and immunology. He recommended that after RIF or 3 or more failed IVF cycles these 2 factors should be investigated. 

Professor Adam Balen, Professor of Reproductive Medicine at Leeds Hospital in the UK and member of FIGO, released a new classification of disorders of ovulation (#1 cause of female infertility) – known as the HyPOP classification: Hypothalamic Pituitary Ovarian PCOS. 

This tool is another major advancement that puts the whole field of infertility into a new phase of progress allowing for greater investigation and treatment.

Another lecture, “The Forgotten Father – Male Factors in Miscarriage” was delivered by Dr. Stephen Gordon of the Center of Reproductive Immunology and Pregnancy. Dr. Gordon brought the guidelines from the American Urology Association, or AUA, in 2021: In couples with failed ART cycles or RPL, the male partner should be evaluated with a focus on sperm DNA. The European Association of Urology, or EAU, in 2020 states that couples with RPL and men with unexplained male infertility indicate that sperm DNA may be damaged. The new 6th Edition WHO recommends testing DFI (DNA Fragmentation Indix) as a cause for infertility and/or miscarriages. 

Dr. Sarah Robertson delivered a lecture on the topic of immunotherapy. Dr. Robertson posited that a healthy immune response helps pregnancy success, and focused on the importance of immune response in helping healthy implantation and placental development. In Dr. Robertson’s opinion, poor immune response raises the risk of pregnancy loss, specifically with first pregnancy or RIF.

In order to improve immune response, one should first incorporate lifestyle changes: increase vegetable and protein in one’s diet, and exercise, considering that people with obesity have weaker immune profiles. 

The next step would be medications: Intra-lipid, IVIG, and others, which in some cases would be beneficial and recommended for immune disorders.

UTERINE TRANSPLANTS: THE WAVE OF THE FUTURE

At a recent Israeli conference, Rabbi Melber was fortunate to meet Dr.  Ben-Shachar, who is developing a method for uterine transplants which has already been approved by the Israeli government. This procedure will be free for Israelis – with the same high level treatment as in the US, where it costs roughly $300,000!

In general, it is often worthwhile for couples to come to Israel for fertility treatments, which are considerably more affordable even when paying privately.

TAHAREINU LIVE SHIURIM – COMING TO YOUR COMMUNITY!

Tahareinu had the honor hosting 6 shiurim around Yerushalaim during the past 4 weeks. Four shiurim were given to Rabbonim in Ramat Eshkol, Romemma, Bircas Moshe and Ganei Geulah, and two shiurim for women in the Sanhedria/Ramat Eshkol neighborhoods. Tahareinu will I”H be hosting shiurim in Melbourne, AU during the month of Tammuz, along with multiple shiurim in the Arze Habira neighborhood of Yerushalaim. 

If you would like Tahareinu to come to your community please reach out to tzvi.goldman@tahareinu.com.

In the past 8 weeks we’ve hosted shiurim in:

TAHAREINU PROFESSIONAL COURSE – LAST CHANCE!

Our English course is sold out and underway, with close to 100 Rabbanim, Kallah teachers, and professionals from around the world enrolled. (The course is recorded, for information pertaining to the course/recordings please email tzvi.goldman@tahareinu.com

The Yiddish course is starting this Monday, July 4! To enroll, please email tzvi.goldman@tahareinu.com

Dear Friends, 

As we revel in the summer sun, we look optimistically at a future full of innovation and renewal. 

In this newsletter, we bring you good news for the Lakewood community and indeed the entire tri-state area. 

We are also including eye-opening updates from several conferences that created a stir in the OB/GYN arena. 

As always, we encourage you to reach out with any comments, questions, or requests. 

Wishing you a happy and healthy summer, 

Yitzchok Melber

WE ARE HONORED TO ANNOUNCE:

The opening of a new fertility clinic is always a reason for hope and excitement. But never have we been as delighted as we are now – with the launch of Conceive NJ, a state-of-the-art fertility center in the heart of Lakewood, NJ under the helm of our dear friend Dr. Isaac Glatstein. 

Dr. Glatstein has spent 22 years as the director of the IVF Center at Harvard University, overseeing the births of 70,000 babies, and has always been a visionary in the field. Now, he brings his expertise, sensitivity, and uniquely caring nature to the Orthodox community of Lakewood and beyond.

Rabbi and Mrs. Melber were privileged to meet with Dr. Glatstein and have only the most effusive praise. This is an incredible new revolution for the couples in our community facing infertility. 

Conceive NJ will offer the full workup and treatments to the community with cutting-edge treatments & procedures. 

Dr. Glatstein traveled the world in the last few years going to seminars and conferences bringing the latest innovations in treatments, processes and procedures, bringing these services in-house. 

Rabbi Melber’s warm and hearty relationship with Dr. Glatstein has been cemented throughout their mutual attendance at many medical conferences, and they continued to be in touch at every juncture throughout the planning and building stages of this unique facility. 

The care is personalized and culturally sensitive, which are both so essential to couples in this vulnerable state. 

We extend a warm and heartfelt Bracha to this incredible doctor and his dedicated team – may they see Hatzlacha in their hallowed endeavor and be Zoche to see many more Neshamos enter the world through their incredible care. 

Dr. Glatstein has a long-standing relationship with Tahareinu and the Lakewood community, speaking at the annual Tahareinu conference for Rabbonim and Kallah Teachers in Lakewood multiple times over the past few years.

Appointments can be made by calling the office at 732-806-1613, visiting their website conceivenj.com, or emailing info@conceivenj.com.

RABBI MELBER ATTENDS RCOG CONFERENCE

The Royal College of Gynecology conference in England takes place only once in 3 years – and is always a hotbed of innovation. 

Professor Joop Laven M.D PH.D. announced new guidelines for PCOS. Until now, in order to diagnose PCOS, a patient had to have 2 out of the 3 main symptoms: Acne, irregular cycles, and an ultrasound showing (many) undeveloped follicles.  

The updated recommendation (in addition to the above symptoms) for diagnosing PCOS has changed to include a simple AMH blood test. The benefits include easier access and greater clarity, as well as determining POI issues simultaneously. 

In the States and the UK this test is covered; in Israel it is still private. 

Dr. Scott Nelson delivered a lecture on role of AMH in fertility preservations and beyond. Whenever the question of whether to freeze eggs or not arises, either because someone is approaching age 30, has endometriosis, or, is undergoing chemo – how do we determine the protocol? 

Usually AMH can give us the info regarding the ovarian reserve in order to provide the answer. 

Oncology patients should undergo egg-freezing before starting chemotherapy treatments, and perform the test before and after chemotherapy. Girls who have not begun menstruating by their late teens, or, who have not had a period for a full year should take this test and repeat it every year that their AMH is showing low.

AMH has a wealth of additional uses that are now beginning to be fully realized. 

At Tahareinu, we recommend this test often when we see the need.

Dr. Ippokratis Sarris, Director and Consultant in Reproductive Medicine at King’s Fertility delivered another lecture focusing on two reasons for failed IVF: Thrombophilia (clotting) and immunology. He recommended that after RIF or 3 or more failed IVF cycles these 2 factors should be investigated. 

Professor Adam Balen, Professor of Reproductive Medicine at Leeds Hospital in the UK and member of FIGO, released a new classification of disorders of ovulation (#1 cause of female infertility) – known as the HyPOP classification: Hypothalamic Pituitary Ovarian PCOS. 

This tool is another major advancement that puts the whole field of infertility into a new phase of progress allowing for greater investigation and treatment.

Another lecture, “The Forgotten Father – Male Factors in Miscarriage” was delivered by Dr. Stephen Gordon of the Center of Reproductive Immunology and Pregnancy. Dr. Gordon brought the guidelines from the American Urology Association, or AUA, in 2021: In couples with failed ART cycles or RPL, the male partner should be evaluated with a focus on sperm DNA. The European Association of Urology, or EAU, in 2020 states that couples with RPL and men with unexplained male infertility indicate that sperm DNA may be damaged. The new 6th Edition WHO recommends testing DFI (DNA Fragmentation Indix) as a cause for infertility and/or miscarriages. 

Dr. Sarah Robertson delivered a lecture on the topic of immunotherapy. Dr. Robertson posited that a healthy immune response helps pregnancy success, and focused on the importance of immune response in helping healthy implantation and placental development. In Dr. Robertson’s opinion, poor immune response raises the risk of pregnancy loss, specifically with first pregnancy or RIF.

In order to improve immune response, one should first incorporate lifestyle changes: increase vegetable and protein in one’s diet, and exercise, considering that people with obesity have weaker immune profiles. 

The next step would be medications: Intra-lipid, IVIG, and others, which in some cases would be beneficial and recommended for immune disorders.

UTERINE TRANSPLANTS: THE WAVE OF THE FUTURE

At a recent Israeli conference, Rabbi Melber was fortunate to meet Dr.  Ben-Shachar, who is developing a method for uterine transplants which has already been approved by the Israeli government. This procedure will be free for Israelis – with the same high level treatment as in the US, where it costs roughly $300,000!

In general, it is often worthwhile for couples to come to Israel for fertility treatments, which are considerably more affordable even when paying privately.

TAHAREINU LIVE SHIURIM – COMING TO YOUR COMMUNITY!

Tahareinu had the honor hosting 6 shiurim around Yerushalaim during the past 4 weeks. Four shiurim were given to Rabbonim in Ramat Eshkol, Romemma, Bircas Moshe and Ganei Geulah, and two shiurim for women in the Sanhedria/Ramat Eshkol neighborhoods. Tahareinu will I”H be hosting shiurim in Melbourne, AU during the month of Tammuz, along with multiple shiurim in the Arze Habira neighborhood of Yerushalaim. 

If you would like Tahareinu to come to your community please reach out to tzvi.goldman@tahareinu.com.

In the past 8 weeks we’ve hosted shiurim in:

TAHAREINU PROFESSIONAL COURSE – LAST CHANCE!

Our English course is sold out and underway, with close to 100 Rabbanim, Kallah teachers, and professionals from around the world enrolled. (The course is recorded, for information pertaining to the course/recordings please email tzvi.goldman@tahareinu.com

The Yiddish course is starting this Monday, July 4! To enroll, please email tzvi.goldman@tahareinu.com

Dear Friends, 

As we revel in the summer sun, we look optimistically at a future full of innovation and renewal. 

In this newsletter, we bring you good news for the Lakewood community and indeed the entire tri-state area. 

We are also including eye-opening updates from several conferences that created a stir in the OB/GYN arena. 

As always, we encourage you to reach out with any comments, questions, or requests. 

Wishing you a happy and healthy summer, 

Yitzchok Melber

WE ARE HONORED TO ANNOUNCE:

The opening of a new fertility clinic is always a reason for hope and excitement. But never have we been as delighted as we are now – with the launch of Conceive NJ, a state-of-the-art fertility center in the heart of Lakewood, NJ under the helm of our dear friend Dr. Isaac Glatstein. 

Dr. Glatstein has spent 22 years as the director of the IVF Center at Harvard University, overseeing the births of 70,000 babies, and has always been a visionary in the field. Now, he brings his expertise, sensitivity, and uniquely caring nature to the Orthodox community of Lakewood and beyond.

Rabbi and Mrs. Melber were privileged to meet with Dr. Glatstein and have only the most effusive praise. This is an incredible new revolution for the couples in our community facing infertility. 

Conceive NJ will offer the full workup and treatments to the community with cutting-edge treatments & procedures. 

Dr. Glatstein traveled the world in the last few years going to seminars and conferences bringing the latest innovations in treatments, processes and procedures, bringing these services in-house. 

Rabbi Melber’s warm and hearty relationship with Dr. Glatstein has been cemented throughout their mutual attendance at many medical conferences, and they continued to be in touch at every juncture throughout the planning and building stages of this unique facility. 

The care is personalized and culturally sensitive, which are both so essential to couples in this vulnerable state. 

We extend a warm and heartfelt Bracha to this incredible doctor and his dedicated team – may they see Hatzlacha in their hallowed endeavor and be Zoche to see many more Neshamos enter the world through their incredible care. 

Dr. Glatstein has a long-standing relationship with Tahareinu and the Lakewood community, speaking at the annual Tahareinu conference for Rabbonim and Kallah Teachers in Lakewood multiple times over the past few years.

Appointments can be made by calling the office at 732-806-1613, visiting their website conceivenj.com, or emailing info@conceivenj.com.

RABBI MELBER ATTENDS RCOG CONFERENCE

The Royal College of Gynecology conference in England takes place only once in 3 years – and is always a hotbed of innovation. 

Professor Joop Laven M.D PH.D. announced new guidelines for PCOS. Until now, in order to diagnose PCOS, a patient had to have 2 out of the 3 main symptoms: Acne, irregular cycles, and an ultrasound showing (many) undeveloped follicles.  

The updated recommendation (in addition to the above symptoms) for diagnosing PCOS has changed to include a simple AMH blood test. The benefits include easier access and greater clarity, as well as determining POI issues simultaneously. 

In the States and the UK this test is covered; in Israel it is still private. 

Dr. Scott Nelson delivered a lecture on role of AMH in fertility preservations and beyond. Whenever the question of whether to freeze eggs or not arises, either because someone is approaching age 30, has endometriosis, or, is undergoing chemo – how do we determine the protocol? 

Usually AMH can give us the info regarding the ovarian reserve in order to provide the answer. 

Oncology patients should undergo egg-freezing before starting chemotherapy treatments, and perform the test before and after chemotherapy. Girls who have not begun menstruating by their late teens, or, who have not had a period for a full year should take this test and repeat it every year that their AMH is showing low.

AMH has a wealth of additional uses that are now beginning to be fully realized. 

At Tahareinu, we recommend this test often when we see the need.

Dr. Ippokratis Sarris, Director and Consultant in Reproductive Medicine at King’s Fertility delivered another lecture focusing on two reasons for failed IVF: Thrombophilia (clotting) and immunology. He recommended that after RIF or 3 or more failed IVF cycles these 2 factors should be investigated. 

Professor Adam Balen, Professor of Reproductive Medicine at Leeds Hospital in the UK and member of FIGO, released a new classification of disorders of ovulation (#1 cause of female infertility) – known as the HyPOP classification: Hypothalamic Pituitary Ovarian PCOS. 

This tool is another major advancement that puts the whole field of infertility into a new phase of progress allowing for greater investigation and treatment.

Another lecture, “The Forgotten Father – Male Factors in Miscarriage” was delivered by Dr. Stephen Gordon of the Center of Reproductive Immunology and Pregnancy. Dr. Gordon brought the guidelines from the American Urology Association, or AUA, in 2021: In couples with failed ART cycles or RPL, the male partner should be evaluated with a focus on sperm DNA. The European Association of Urology, or EAU, in 2020 states that couples with RPL and men with unexplained male infertility indicate that sperm DNA may be damaged. The new 6th Edition WHO recommends testing DFI (DNA Fragmentation Indix) as a cause for infertility and/or miscarriages. 

Dr. Sarah Robertson delivered a lecture on the topic of immunotherapy. Dr. Robertson posited that a healthy immune response helps pregnancy success, and focused on the importance of immune response in helping healthy implantation and placental development. In Dr. Robertson’s opinion, poor immune response raises the risk of pregnancy loss, specifically with first pregnancy or RIF.

In order to improve immune response, one should first incorporate lifestyle changes: increase vegetable and protein in one’s diet, and exercise, considering that people with obesity have weaker immune profiles. 

The next step would be medications: Intra-lipid, IVIG, and others, which in some cases would be beneficial and recommended for immune disorders.

UTERINE TRANSPLANTS: THE WAVE OF THE FUTURE

At a recent Israeli conference, Rabbi Melber was fortunate to meet Dr.  Ben-Shachar, who is developing a method for uterine transplants which has already been approved by the Israeli government. This procedure will be free for Israelis – with the same high level treatment as in the US, where it costs roughly $300,000!

In general, it is often worthwhile for couples to come to Israel for fertility treatments, which are considerably more affordable even when paying privately.

TAHAREINU LIVE SHIURIM – COMING TO YOUR COMMUNITY!

Tahareinu had the honor hosting 6 shiurim around Yerushalaim during the past 4 weeks. Four shiurim were given to Rabbonim in Ramat Eshkol, Romemma, Bircas Moshe and Ganei Geulah, and two shiurim for women in the Sanhedria/Ramat Eshkol neighborhoods. Tahareinu will I”H be hosting shiurim in Melbourne, AU during the month of Tammuz, along with multiple shiurim in the Arze Habira neighborhood of Yerushalaim. 

If you would like Tahareinu to come to your community please reach out to tzvi.goldman@tahareinu.com.

In the past 8 weeks we’ve hosted shiurim in:

TAHAREINU PROFESSIONAL COURSE – LAST CHANCE!

Our English course is sold out and underway, with close to 100 Rabbanim, Kallah teachers, and professionals from around the world enrolled. (The course is recorded, for information pertaining to the course/recordings please email tzvi.goldman@tahareinu.com

The Yiddish course is starting this Monday, July 4! To enroll, please email tzvi.goldman@tahareinu.com

ds,

As we anticipate the celebration of Kabalas Hatorah, we join you in wishing all of Klal Yisroel a wonderful Yom Tov. 

Here at Tahareinu, we remain committed to our mission of spreading awareness about the latest innovations in women’s health and fertility. 

To that end, we share within this edition fascinating new insights gleaned from conferences we’ve attended around the world. 

Read and gain insight! 

Also, look out in your inboxes for details about the well-regarded Tahareinu course for professionals, starting after Shavuos.

Thank you, 

Yitzchok Melber

RABBI AND MRS. MELBER ATTEND ACOG CONFERENCE IN SAN DIEGO

HTRS: TECHNOLOGY REVOLUTION IN HYSTEROSCOPY

Professor Chaimovitz, head of OB/GYN in Laniado Hospital, presented this innovation.

HTRS, or hysteroscopic tissue removal systems, are set to replace D&C throughout the medical world. 

The facts are:

With blind D&C, only 50% of the uterine cavity is viewed in 60% of cases. 

With blind D&C, only 40% of placental remains are removed. 

This technology combines a hysteroscopy with a new machine that can remove not only polyps, fibroids, and adhesions, but products of conception much more effectively as well. 

The conclusion? This should be the new standard of care and completely replace blind D&C.

RABBI AND MRS. MELBER IN CHICAGO, LAKEWOOD, BROOKLYN & YERUSHALAYIM

Following the ACOG, Rabbi and Mrs. Melber flew to Chicago. 

Rabbi Melber presented an extremely comprehensive two-day seminar to Rabbanim, and Mrs. Melber presented to the Kallah teachers. 

They also met with couples and individually with local professionals. 

In Brooklyn and Lakewood, Rabbi Melber presented at the Tahareinu yearly conference with over 120 Rabbanim in attendance. 

One topic that was highlighted was Progesterone. 

On the one hand, progesterone is notorious for causing trouble such as AUB, irregular cycles, and staining. 

However, when administered properly – in the correct time, form, and dose – it is extremely effective and is in fact the solution to many common challenges. 

Many women naturally have low progesterone, and common symptoms include spotting, infertility, and miscarriages. 

Each case and scenario must be evaluated carefully and the right guidance must be given. We were pleased to present this crucial information to the Rabbanim so they can in turn be of help to their communities. 

Of course, guidance must be double checked with one’s doctor for clarity. 

OTHER UPDATES:

• As we’ve mentioned before, the first line treatment for overweight PCOS patients is to lose just 5% of their body weight, which can have overall positive effects on their fertility. 
• The 6th version of semen analysis was recently released, which includes an expanded investigation and a particular focus on DFI (DNA Fragmentation Index). All labs should be including this option soon, and it is Halachically preferable as it will only require one sample vs. an additional sample for DFI.
• Dr. Bar-Tuv, Dr. Barak and Dr. Peretz of Israel published research for the success rate of the Microscopic testicular sperm extraction (microTESE) procedure when combined with the IMS method. The research shows a greater success rate when these techniques are combined. This is currently only performed in Israel, and couples do travel to Israel to have this treatment. 
• When Rabbi Melber presented in Boro Park along with fertility expert Dr. Michael Werner, he recommended TRT (testosterone replacement therapy) for males with under 300 units in order to boost fertility. He recommended under 300 units should be treated

See below for information on our upcoming webinar!

BS"DDear Friends,The beautiful spring weather speaks of renewal and rejuvenation, and at Tahareinu we are constantly in a state of innovation as well. At this month’s conferences, new information was unveiled by expert from across the globe, and we are pleased to...

BS"D Dear Friends, Pesach prep is in full swing throughout every Jewish community – and we hope this joyous season finds you healthy and happy.At Tahareinu, every season finds us exploring the latest innovations in women’s health and fertility – at conferences,...

BS"DDear Friends,The season of Simcha is in full swing at Tahareinu and throughout Klal Yisrael…We welcome you once again to our environs, where innovation and education are the hallmarks of our work.Please enjoy these updates on our recent whirlwind trip to the New...

This is the excerpt about the event.

BS"D Dear Friend, Though the trees are bare and the gusty winds blow, here at Tahareinu we feel warmth, connection, and hope. Coming off a positively electric annual campaign, we are inspired by your participation, your encouragement, and your championship of the...

BS"D Dear Friends of Tahareinu, As the temperature drops and we all prepare for the cold stretch ahead, the Tahareinu office remains warm and inviting as ever. Couples consult. Doctors discuss. Advisors assist. It’s a hub of activity and a haven of support for...

BS"D Dear Friends, The month of Kislev is synonymous with gratitude, and the Tahareinu team is indeed filled with gratitude for a season of new accomplishments, new knowledge amassed, and new developments underway. It has been our privilege to make a whirlwind trip to...

BS"DDear Friends,As we settle into the month of Cheshvan, we look back at an incredibly successful Yom Tov season with gratitude and pride.As Tahareinu’s work expands and our repertoire of services grows, we remain true to our original mission:Bringing every Jewish...

BS"D Dear Friends, With the new year’s beginning, we join you in hope and Tefillah for a year of growth, health, and healing. At Tahareinu, we are pleased to be starting the new year in our new and expanded office in Israel, an auspicious symbol of growth and...

BS"D Dear Friends, As the month of connection and growth progresses, it is our privilege to share with you the latest discoveries and advancements at Tahareinu. With gratitude to Hashem, we can report much progress and growth as well as tremendous feedback from our...

BS"D Dear Friends, It may feel incongruous to celebrate all of Tahareinu’s recent accomplishments at a time designated for deep mourning. But in truth, we hope our efforts to create awareness and assist thousands of couples will have a small part in bringing the...

BS"DDear Friends,We are overjoyed by your thirst for knowledge and the desire to pass it on to your communities. As we write this, over 120 people are enrolled in our three current Tahareinu courses: Professional Certification (both English and Yiddish) as well as a...

BS"D Over 1700 Attend Tahareinu "TED Talk" Style Webinar Dear Friends, Call it Tahareinu Torahs. As we near the end of Omer count in preparation to receive the Torah, we at Tahareinu are increasingly expanding our reach to fellow Jews thirsty for the "Torahs" we give...

BS"DExciting InnovationsDear Friends,Read below for Tahareinu's latest promising updates on fertility and reproductive health, gleaned from the many global medical conferences our leadership attended in the past few weeks. Israel Office Open for In-PersonWe are zocheh...

Wishing all our supporters a חג כשר ושמח Let's raise our cups to our commitment to providing SERVICE EXCELLENCE. We thank you for your support in enabling us to offer a higher level of service this winter.This past year was not an easy one for individuals and...

BS"DIt's Been A Full YearDear Friends,A year ago, we went from Purim masks to daily masks, and now Purim is upon us again.As you may know, Tahareinu pivoted immediately to continue all of our services remotely, and our leadership attended medical conferences via Zooms...

BS"DDear Friends,We hope your Chodesh Shvat is going well. With this month we welcome the New Year of the Trees, appreciating Hashem's handiwork in the fruits we consume each season, while taking the opportunity to metaphorically focus on our own long-term "growth."In...

A Freilichen Hanukah 5781 Tahareinu Wishes You A Happy Hanukah SPREAD THE LIGHT Tahareinu's annual campaign is planned for early January 2021. Be an Ambassador. Find out details HERE Looking forward to shining light year round.Yours, Rabbi Yitzchok and Mrs. Chaya...

BS"DDear Friends,Chodesh tov. Kislev provides us the welcome opportunity to bask in and spread light to our fellow Yidden. We at Tahareinu are zocheh to bring light to people in need every day. The numbers of hotline calls and consultations keeps rising, and we're now...

BS"DDear Friends,We were ecstatic this past Tuesday, seeing over 400 people attend our first-ever live webinar. The topic was Medical Innovations for Couples' Health - a 2019-2020 Review.Immediate feedback included the following appraisals:"Excellent! It's so amazing...

What a Year! B"H Good News to Report Dear Friends, We are about to enter the new year with so much uncertainty that we are constantly surrounded by the opportunity to acknowledge that HaKadosh Baruch Hu is the only One who knows the true plan. B"H, one thing that...

BS"D The King is in the Field Dear Friends,Chodesh tov, and b'sorot tovot. Right at the onset of Elul, we were extremely saddened by the passing of HaGaon HaRav Zalman Nechemia Goldberg of Yerushalayim. Known as Reb Zalman Nechemia, he was a pillar for Tahareinu -...

Making it happen Dear Friends, Chodesh Menachem Av tov. We have entered the month when we are sincerely focused on bringing back the Beis HaMikdash, bimheira beyameinu. We certainly feel it so much more these days, trying desperately to keep healthy, and not knowing...

BS"D So Good to Have Good News Dear Friends, Chodesh tov! With all that's going on with COVID-19, we are so happy to be able to share so much good news this month, as well as return to our usual newsletter forum, highlighting various doctors and procedures related to...

BS"D Dear Tahareinu Family in Minneapolis, We hope your Shavuos preparations are going well. During this challenging "new normal," we wish everyone a very special Matan Torah, receiving the Torah with new insights to inspire us no matter what the situation. Speaking...

Corona Update BS"D HERE FOR YOU, NOW MORE THAN EVER Dear Friends, Coronavirus is affecting our communities greatly. Once it became clear that the virus was spreading globally, Tahareinu instantly embarked on a Corona Initiative, ensuring we could continue helping...

BS"D Prep Time Dear Friends, It's that excitingly hectic time of year, when we prepare our homes for the Festival of Freedom. At Tahareinu we are zocheh to bring freedom to couples throughout the year, freeing up women to achieve tahara and alleviate gynecological...

Unmasking Your Solutions Dear Friends, Chodesh tov! As Adar reins in, so do all of our Purim preparations - both physical and spiritual. A major theme for Purim is how 'masked' we can be in daily life, and the holiday provides us the opportunity to ponder our masks in...

BS"D Growing with You Dear Friends, This past month, we enjoyed educating communities and bolstering support during our PURE Family campaigns inMontreal, New York, and New Jersey! As usual, our hotline and case management continue as busy as ever, helping hundreds of...

Yearly Z'chus BS"D The Merit of Pure Family Life Dear Friends,We are overwhelmingly thrilled to invite you to participate in our annual campaign. This year, we are hosting campaign bases in four Tahareinu strongholds- Montreal, New York City, London and Jerusalem...

BS"D Daily Miracles Dear Friends,Kislev is here, and with it, the topic of pirsumei nisa imparting the Chanukah miracle by lighting the Chanukiah in a location viewable to passersby. Tahareinu, Baruch Hashem, strives to bring light year-round to you or people you...

BS"D Inspired by Rachel Imeinu Dear Friends,The month of Cheshvan marks Rachel Imeinu's yahrzeit, reminding us about her years of struggle with infertility, and her sad passing after giving birth to Binyamin. Rachel's story emphasizes how central a mother's...

Cutting-edge medical strategiesTaharat hamishpacha, fertility, and women's reproductive health בס"ד Shana Tovah:A year of branching out Dear Friends,Reflecting on Tahareinu's fastest-paced year in our decade of existence, we are inspired by the increasing number of...

Solutions for women and couples. New strategies for doctors. Taharat hamishpacha, fertility, and women's reproductive health. Medical Institutions Now Approach Tahareinu Shalom, Word has spread: Medical institutions are becoming aware that Tahareinu's superior...